Search for: "Shire LLCĀ " Results 21 - 40 of 92
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Dec 2017, 7:08 pm by Ben Vernia
  Shire Pharmaceuticals LLC paid $350 million to resolve allegations that Shire and the company it acquired in 2011, Advanced BioHealing (ABH), induced clinics and physicians to use or overuse its bioengineered human skin substitute by offering lavish dinners, drinks, entertainment and travel; medical equipment and supplies; unwarranted payments for purported speaking engagements and bogus case studies; and cash, credits and rebates. [read post]
13 Apr 2017, 9:44 am by Jo Dale Carothers
Shire LLC, the PTAB instituted review of claims 18-21, 23 and 25 of Shire’s patent for the attention deficit and hyperactivity disorder medication known as Adderall XR. [read post]
19 Jan 2017, 10:37 am by admin
Lee Bentley, III, United States Attorney in the Middle District of Florida recently announced a $350 million settlement between Shire Pharmaceuticals LLC and the Government. [read post]
19 Jan 2017, 10:37 am by admin
Lee Bentley, III, United States Attorney in the Middle District of Florida recently announced a $350 million settlement between Shire Pharmaceuticals LLC and the Government. [read post]
11 Jan 2017, 10:50 am
Shire Pharmaceuticals LLC and other subsidiaries of Shire plc (Shire) will pay $350 million to settle federal and state False Claims Act allegations that Shire and Advanced BioHealing (ABH) — a company it acquired in 2011 — employed kickbacks and other unlawful methods to induce clinics and physicians to use or overuse its product “Dermagraft,” a... [read post]
11 Jan 2017, 10:50 am
Shire Pharmaceuticals LLC and other subsidiaries of Shire plc (Shire) will pay $350 million to settle federal and state False Claims Act allegations that Shire and Advanced BioHealing (ABH) — a company it acquired in 2011 — employed kickbacks and other unlawful methods to induce clinics and physicians to use or overuse its product “Dermagraft,” a... [read post]
14 Jun 2015, 7:30 pm by Lawrence B. Ebert
The inter partes review of the '813 patent was based on a petition initiated by Shire Development LLC that alleged the patent would have been obvious at the time of its invention on September 13, 2007 and therefore was invalid. [read post]
4 Jun 2015, 7:25 am by Lawrence B. Ebert
No infringement because of estoppel and invalidity through lack of enablement.CAFC in Shire v. [read post]
28 Jan 2015, 10:00 pm by Courtenay C. Brinckerhoff
On January 26, 2015, the Supreme Court granted certiorari, vacated, and remanded Shire Development LLC v. [read post]